Bristol Myers Squibb reported strong fourth-quarter earnings but its outlook for 2025 failed to meet expectations.

C3.ai is capturing strong demand for commercial AI solutions with tools to improve productivity and operational efficiency.

Here are three fantastic biotech stocks harnessing the power of AI that could make a great addition to your portfolio. The ...

Dutch Bros ( BROS -0.08%) shares are soaring, up 87% just in the past three months. Investors are clearly energized about the ...

The company's fourth-quarter earnings report, released on Jan. 21, confirmed what many investors already knew about the stock. 3M isn't getting much help from its end markets, but its ongoing ...

In the final two months of 2024, XRP ( XRP -5.44%) was one of the best-performing cryptocurrencies in the world. In that ...

Atlassian is unlocking a new phase of growth thanks to artificial intelligence (AI), which is a key reason its stock has more ...

However, the rising popularity of GLP-1 drugs, which are highly effective in helping people lose weight and also reduce the ...

Super Micro has not filed a quarterly or annual report since June 2024, when it posted its results for the first three months ...

Kenvue posted mixed Q4 earnings, with in-line EPS but revenue below estimates, driven by challenges in its Skin Health and ...